首页 > 市场调查报告书 > 材料

杀虫剂

市场调查报告书

商品编码

1547530

全球异噁唑啉市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Isoxazoline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计全球异噁唑啉市场需求将从2023年的16亿美元达到2032年近54.5亿美元的市场规模，2024-2032年研究期间复合年增长率为14.55%。

异噁唑啉是一类五元杂环化合物，包含彼此邻近的氧和氮各一个原子。它可以透过腈氧化物与烯烃的1,3-偶极环加成反应、2-异噁唑啉的N-甲基化反应以及硝酮和炔烃之间的环加成反应来製备。异噁唑啉有多种用途，其中许多具有生物活性。它们具有广谱的杀虫和杀螨活性，可有效对抗跳蚤和蜱等许多兽医寄生虫。

市场动态

预计全球异噁唑啉市场在预测期内将以稳定的速度成长。对宠物的寄生虫攻击不断增加、对异噁唑啉潜力的研究不断深入以及宠物拥有量的增加是引导全球异噁唑啉市场的因素。由于具有杀虫、抗菌、抗生素、抗肿瘤、抗真菌、抗结核、抗癌和致溃疡等特性，异噁唑啉在药物和治疗学中的用途和探索正在不断扩大。此外，异噁唑啉作为抗癌剂在药物化学领域具有重要意义。然而，FDA 几乎没有收到关于异噁唑啉可能对狗和猫造成神经系统不良事件的警告，这限制了市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对异噁唑啉全球市场的每个细分市场进行了包容性评估。异噁唑啉产业的成长和趋势为本研究提供了整体方法。

市场区隔

异噁唑啉市场报告的这一部分提供了国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

依产品类型

氟拉纳
阿福奥拉纳
萨罗拉纳
洛蒂拉纳

依宠物类型

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲异噁唑啉市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。异噁唑啉市场的主要参与者包括默克动物保健公司、Elanco 动物保健公司、勃林格殷格翰国际有限公司、硕腾公司等。发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：异噁唑啉公司的竞争格局

异噁唑啉市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Merck Animal Health Inc

公司概况
公司收入
产品
最新动态

Elanco Animal Health Incorporated

公司概况
公司收入
产品
最新动态

Boehringer Ingelheim International GmbH

公司概况
公司收入
产品
最新动态

Zoetis Inc. Etc

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11215055

The global demand for Isoxazoline Market is presumed to reach the market size of nearly USD 5.45 Billion by 2032 from USD 1.6 Billion in 2023 with a CAGR of 14.55% under the study period 2024-2032.

Isoxazoline is a class of five-membered heterocyclic compounds, comprising one atom each of oxygen and nitrogen, located adjacent to each other. It can be produced by the 1,3-dipolar cycloaddition of nitrile oxides with alkenes, 2-isoxazolines by N-methylation, and cycloaddition between a nitrone and an alkyne. Isoxazolines have a variety of uses, with many being biologically active. They exhibit a broad spectrum of insecticidal and acaricidal activity and are effective against many veterinary parasites such as fleas and ticks.

MARKET DYNAMICS

The global isoxazoline market is estimated to grow at a steady rate during the forecast period. Increasing parasite attacks on pets, advancing research on the potentials of isoxazoline, and rising pet ownership are factors steering the global isoxazoline market. Isoxazoline is finding its expanding use and exploration in pharmaceuticals and therapeutics due to the properties such as insecticidal, antibacterial, antibiotic, antitumor, antifungal, antituberculosis, anticancer, and ulcerogenic. In addition, Isoxazoline has gained much significance in the field of medicinal chemistry as an anticancer agent. However, few alerts were received from the FDA about isoxazoline's potential for neurologic adverse events in dogs and cats, restraining market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Isoxazoline. The growth and trends of Isoxazoline industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Isoxazoline market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Fluralaner
Afoxolaner
Sarolaner
Lotilaner

By Pet Type

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Isoxazoline market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Isoxazoline market include Merck Animal Health Inc, Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Zoetis Inc. Etc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ISOXAZOLINE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Pet Type
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ISOXAZOLINE MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Fluralaner Historic and Forecast Sales By Regions
5.4. Afoxolaner Historic and Forecast Sales By Regions
5.5. Sarolaner Historic and Forecast Sales By Regions
5.6. Lotilaner Historic and Forecast Sales By Regions

6. GLOBAL ISOXAZOLINE MARKET ANALYSIS BY PET TYPE

6.1. Overview By Pet Type
6.2. Historical and Forecast Data Analysis By Pet Type
6.3. Cat Historic and Forecast Sales By Regions
6.4. Dog Historic and Forecast Sales By Regions

7. GLOBAL ISOXAZOLINE MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE ISOXAZOLINE COMPANIES

8.1. Isoxazoline Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF ISOXAZOLINE INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Merck Animal Health Inc
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Elanco Animal Health Incorporated
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Boehringer Ingelheim International GmbH
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Zoetis Inc. Etc
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments